Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

Brief Report: Improving Lung Cancer Screening Rates: A Pilot Program for Low-Dose CT Implementation in a Community

Maha Zafar1, Manaswini Krishnakumar2, Natasha Dudiki3

  • 1Department of Hospice and Palliative Care, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY.

Clinical Lung Cancer
|May 22, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HSR26-196: Experience With Pertuzumab-Based Neoadjuvant Therapy in HER2-Positive Breast Cancer: Treatment Patterns, Discontinuation, and Residual Disease Outcomes.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

HSR26-196: Experience With Pertuzumab-Based Neoadjuvant Therapy in HER2-Positive Breast Cancer: Treatment Patterns, Discontinuation, and Residual Disease Outcomes.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102).

Journal of the National Cancer Institute·2026
Same author

Elevated Epicardial Adipose Tissue and Ischemic Stroke Risk: A Systematic Review and Meta-Analysis.

Medicina (Kaunas, Lithuania)·2025
Same author

Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis.

Nefrologia·2025
This summary is machine-generated.

This pilot lung cancer screening program significantly boosted low-dose computed tomography (LDCT) use, increasing early detection rates. Coordinated care improved lung cancer diagnosis and shows promise for reducing mortality.

Area of Science:

  • Oncology
  • Public Health
  • Radiology

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • Late-stage diagnosis contributes to low survival rates.
  • Early detection through screening is crucial for improving outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of a pilot lung cancer screening program.
  • To improve the utilization of low-dose computed tomography (LDCT) for early lung cancer detection.
  • To assess the impact of coordinated care on screening rates and diagnosis.

Main Methods:

  • Implementation of a structured shared decision-making process with primary care physicians (PCPs).
  • Inclusion of a dedicated nodule navigator to streamline patient care.
Keywords:
Cancer preventionEarly diagnosisLow dose screening CTSmoking

Related Experiment Videos

Last Updated: May 24, 2026

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

  • Establishment of expedited diagnostic pathways for suspicious findings.
  • Data collection on LDCT screening rates and lung cancer diagnoses over a 3-year period.

    • Main Results:

    • LDCT screening rates increased from 32% to 76% within the first year.
    • Over 6126 patients were referred for LDCT screening in 3 years, exceeding the target of 50% screening rates.
    • The program led to an increase in lung cancer diagnoses, indicating successful early detection.

    Conclusions:

    • The pilot program demonstrated significant improvements in lung cancer screening utilization.
    • Coordinated care and early intervention strategies are effective in enhancing early detection.
    • The findings suggest the potential for broader implementation to reduce lung cancer mortality.